Cargando…
Ultra-early tranexamic acid after subarachnoid hemorrhage (ULTRA): study protocol for a randomized controlled trial
BACKGROUND: A frequent complication in patients with subarachnoid hemorrhage (SAH) is recurrent bleeding from the aneurysm. The risk is highest within the first 6 hours after the initial hemorrhage. Securing the aneurysm within this timeframe is difficult owing to logistical delays. The rate of recu...
Autores principales: | Germans, Menno R, Post, René, Coert, Bert A, Rinkel, Gabriël JE, Vandertop, W Peter, Verbaan, Dagmar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658919/ https://www.ncbi.nlm.nih.gov/pubmed/23680226 http://dx.doi.org/10.1186/1745-6215-14-143 |
Ejemplares similares
-
Update of the ULtra-early TRranexamic Acid after Subarachnoid Hemorrhage (ULTRA) trial: statistical analysis plan
por: Post, René, et al.
Publicado: (2020) -
Aneurysm treatment within 6 h versus 6–24 h after rupture in patients with subarachnoid hemorrhage
por: Vergouwen, Mervyn DI, et al.
Publicado: (2023) -
Prehemorrhage antiplatelet use in aneurysmal subarachnoid hemorrhage and impact on clinical outcome
por: Sebök, Martina, et al.
Publicado: (2021) -
Laboratory biomarkers of delayed cerebral ischemia following subarachnoid hemorrhage: A systematic review
por: Tjerkstra, Maud A., et al.
Publicado: (2023) -
Short-term tranexamic acid treatment reduces in-hospital mortality in aneurysmal sub-arachnoid hemorrhage: A multicenter comparison study
por: Post, R., et al.
Publicado: (2019)